Equity Research, Broker Reports, and media content on Novartis AG

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Novartis AG
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Novartis AG

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Novartis AG. We currently have 156 research reports from 6 professional analysts.

Date Source Announcement
29Jan20 06:00 GNW Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019
06Jan20 06:00 GNW Novartis completes tender offer for all outstanding shares of The Medicines Company
16Dec19 06:15 GNW Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
05Dec19 06:00 GNW Novartis tender offer for The Medicines Company commences
24Nov19 20:00 GNW Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
15Nov19 20:06 GNW New Novartis medicine Adakveo® (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
01Nov19 06:15 GNW Novartis Cosentyx® shows encouraging results versus Humira®* from first-of-its-kind head-to-head trial in psoriatic arthritis
  • Frequency of research reports

     

  • Research reports on

    Novartis AG

  • Providers covering

    Novartis AG